A fluorescent nanoprobe could become a universal, noninvasive method to identify and monitor tumors
A*STAR researchers have developed a hybrid metal–polymer nanoparticle that lights up in the acidic environment surrounding tumor cells. Nonspecific probes that can identify any kind of tumor are extremely useful for monitoring the location and spread of cancer and the effects of treatment, as well as aiding initial diagnosis.
Cancerous tumors typically have lower than normal pH levels, which correspond to increased acidity both inside the cells and within the extracellular microenvironment surrounding the cells. This simple difference between tumor cells and normal cells has led several research groups to develop probes that can detect the low pH of tumors using optical imaging, magnetic resonance and positron emission tomography.
Most of these probes, however, target the intracellular pH, which requires the probes to enter the cells in order to work. A greater challenge has been to detect the difference in extracellular pH between healthy tissue and tumor tissue as the pH difference is smaller. Success would mean that the probes are not required to enter the cells.
“Our aim is to address the challenge of illuminating tumors universally,” says Bin Liu from the A*STAR Institute of Materials Research and Engineering. Liu’s team, together with colleagues from the National University of Singapore, based their new probe on polymers that self-assemble on gold nanoparticles. The resulting hybrid structure is not fluorescent at normal physiological pH values: instead acidic conditions similar to those around tumor cells of approximately pH 6.5 alter chemical groups on the surface of the probes and switch on their fluorescence.
After validating the switching mechanism in pH-controlled solutions, the researchers tested the probes using cultured cells and also in tumor-bearing mice illuminated under bright light. Twenty-four hours after injection into the mice, obvious and clear fluorescence was seen only from tumor-bearing tissue, using either whole-body imaging or examination of removed organs (see image). The ability to observe the fluorescence of tumors using noninvasive whole-body examination of living mice indicates the potential of the nanoprobes for use in clinical situations with human patients.
“Our probes have so far proved to be biocompatible, which will be crucial for biomedical applications,” says Liu. “We now plan to check further for any toxicity issues and assess the biological distribution and pharmacological profile of the probes before hopefully moving on to clinical trials,” she adds. This is the latest of several recent advances in nanoscale medical technology from Liu’s group.
 Yuan, Y., Ding, D., Li, K., Liu, J. & Liu, B. Tumor-responsive fluorescent light-up probe based on a gold nanoparticle/conjugated polyelectrolyte hybrid. Small 10, 1967–1975 (2014).
A*STAR Research | ResearchSEA
Historical rainfall levels are significant in carbon emissions from soil
30.05.2017 | University of Texas at Austin
3D printer inks from the woods
30.05.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt
Scientists have developed a new method of characterizing graphene’s properties without applying disruptive electrical contacts, allowing them to investigate both the resistance and quantum capacitance of graphene and other two-dimensional materials. Researchers from the Swiss Nanoscience Institute and the University of Basel’s Department of Physics reported their findings in the journal Physical Review Applied.
Graphene consists of a single layer of carbon atoms. It is transparent, harder than diamond and stronger than steel, yet flexible, and a significantly better...
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
30.05.2017 | Life Sciences
30.05.2017 | Life Sciences
30.05.2017 | Physics and Astronomy